Showing 1 - 15 of 15 Items
Showing 1 - 15 of 15 Items
Sort By: Relevance
Journal Article
|Research
2025-02-20 • New England Journal of Medicine
2025-02-20 • New England Journal of Medicine
BACKGROUND
Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain u...
Journal Article
|Commentary
Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines
2024-06-01 • Lancet Infectious Diseases
2024-06-01 • Lancet Infectious Diseases
Journal Article
|Commentary
2024-03-01 • Lancet Global Health
2024-03-01 • Lancet Global Health
Journal Article
|Research
2023-04-28 • Lancet Infectious Diseases
2023-04-28 • Lancet Infectious Diseases
BACKGROUND
Current supply shortages constrain yellow fever vaccination activities, particularly outbreak response. Although fractional doses of all WHO-prequalified yellow fever vacc...
Current supply shortages constrain yellow fever vaccination activities, particularly outbreak response. Although fractional doses of all WHO-prequalified yellow fever vacc...
Journal Article
|Commentary
2022-11-02 • NPJ Vaccines
2022-11-02 • NPJ Vaccines
Conference Material
|Video
2022-06-21 • Epicentre Scientific Day Paris 2022
2022-06-21 • Epicentre Scientific Day Paris 2022
Journal Article
|Research
2006-02-06 • Vaccine
2006-02-06 • Vaccine
Yellow fever (YF) is a mosquito-borne vaccine-preventable disease with high mortality. In West Africa, low population immunity increases the risk of epidemic transmission. A cluster surv...
Journal Article
|Research
2018-12-07 • PLOS Neglected Tropical Diseases
2018-12-07 • PLOS Neglected Tropical Diseases
BACKGROUND
Between December 2015 and July 2016, a yellow fever (YF) outbreak affected urban areas of Angola and the Democratic Republic of the Congo (DRC). We described the outb...
Journal Article
|Letter
2001-12-01 • Lancet
2001-12-01 • Lancet
A yellow fever epidemic erupted in Guinea in September, 2000. From Sept 4, 2000, to Jan 7, 2001, 688 instances of the disease and 225 deaths were reported. The diagnosis was laboratory c...
Conference Material
|Abstract
2021-06-10 • Epicentre Scientific Day Paris 2021
2021-06-10 • Epicentre Scientific Day Paris 2021
This presentation provides and overview of fractional dosing and discusses opportunities and barriers for other vaccines.
Fractional dosing of vaccines is considered a dose spar...
Fractional dosing of vaccines is considered a dose spar...
Journal Article
|Research
2021-01-09 • Lancet
2021-01-09 • Lancet
BACKGROUND
Stocks of yellow fever vaccine are insufficient to cover exceptional demands for outbreak response. Fractional dosing has shown efficacy, but evidence is limited to the 17...
Stocks of yellow fever vaccine are insufficient to cover exceptional demands for outbreak response. Fractional dosing has shown efficacy, but evidence is limited to the 17...
Journal Article
|Pre-Print
2022-02-21 • medRxiv
2022-02-21 • medRxiv
Immunization is the most cost-effective health intervention in the world yet, vaccination uptake is still low with less than 50% of children aged 12-23 months fully vaccinated Cameroon. ...
Conference Material
|Video
2021-06-10 • Epicentre Scientific Day Paris 2021
2021-06-10 • Epicentre Scientific Day Paris 2021
Journal Article
|Research
2022-05-10 • Scientific Reports
2022-05-10 • Scientific Reports
Mosquito vectors are a tremendous public health threat. One in six diseases worldwide is vector-borne transmitted mainly by mosquitoes. In the last couple of years, there have been activ...
Conference Material
|Abstract
2022-06-01 • Epicentre Scientific Day Paris 2022
2022-06-01 • Epicentre Scientific Day Paris 2022
BACKGROUND
Current supply shortages constrain vaccination activities and particularly outbreak response. We showed that fractional doses of all 4 WHO-prequalified yellow fever vaccin...
Current supply shortages constrain vaccination activities and particularly outbreak response. We showed that fractional doses of all 4 WHO-prequalified yellow fever vaccin...